Seeking men and women whose metastatic non-small lung cancer (NSCLC) has progressed after platinum doublet chemotherapy and immunotherapy for a study of an investigational drug combination.
We are studying how an investigational drug combination compares to the standard chemotherapy for metastatic non-small cell lung cancer (NSCLC). Participants in this study will be randomly assigned to one of three groups. One group will get the investigational drug combination, one group will get the standard chemotherapy and one group will get only one of the investigational drugs.
What we're hoping for
We hope to evaluate how safely and well an experimental drug combination works compared to the standard chemotherapy for metastatic non-small cell lung cancer (NSCLC)
ClinicalTrials.gov Identifier: NCT03976375